Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040134804> ?p ?o ?g. }
- W2040134804 endingPage "272" @default.
- W2040134804 startingPage "267" @default.
- W2040134804 abstract "Abstract: Gentamicin is an antibiotic that is widely used against serious and life‐threatening gram‐negative infections. However, its clinical use is limited by its nephrotoxicity. Oxidative stress and nitrosative stress are reported to play important role in gentamicin nephrotoxicity. In the present study we investigated whether ebselen, an inhibitor of oxidative stress and nitrosative stress prevents or reduces gentamicin‐induced renal damage in the rat. For this purpose male Wistar rats were divided into five groups and treated as follows. Group 1 (control group): dimethyl sulphoxide, intraperitoneally, Group 2: Gentamicin 100 mg/kg b.wt. subcutaneously, Group 3: 5 mg/g b.wt. ebselen intraperitoneally, Group 4: 2.5 mg/kg b.wt. ebselen followed by 100 mg/kg b.wt. gentamicin subcutaneously one hour later, and Group 5: 5 mg/kg b.wt. of ebselen followed by 100 mg/kg b.wt. gentamicin one hour later for four consecutive days. Nephrotoxicity was evaluated histopathologically by light microscopy, and biochemically by the measurement of the plasma creatinine and urea levels. Parameters of oxidative stress such as reduced glutathione, malondialdehyde, and activities of superoxide dismutase and glutathione peroxidase were measured in the kidney. Serum nitrite and nitrate were measured as indicators of nitrosative stress. Treatment of rats with gentamicin resulted in statistically significant reduction in reduced glutathione levels (51%) and the activities of antioxidant enzymes superoxide dismutase (56%) and glutathione peroxidase (39%) as compared with the controls in the kidneys. Renal malondialdehyde level was increased significantly (43%) as compared with the controls. Plasma creatinine levels, urea levels and nitrite levels were significantly increased (4, 4.5 and 160% times respectively) as compared with the controls. Histologically, damage to the renal cortex and medulla was observed moderate to severe tubular necrosis and glomerular congestion. Pretreatment with 2.5 mg/kg b.wt. ebselen prevented gentamicin induced damage to medulla; however, renal cortex showed mild damage and biochemically indicators of oxidative stress and nitrosative stress were significantly reduced. Pretreatment with 5 mg/kg b.wt. ebselen prevented gentamicin‐induced oxidative damage and nitrosative damage and renal damage almost completely in 78% of the rats, in the other 22% of the rats, ebselen pretreatment reduced gentamicin‐induced renal damage. The results of the present study suggest that ebselen may be useful as a nephroprotective agent." @default.
- W2040134804 created "2016-06-24" @default.
- W2040134804 creator A5016702063 @default.
- W2040134804 creator A5030821072 @default.
- W2040134804 creator A5068972966 @default.
- W2040134804 date "2006-08-23" @default.
- W2040134804 modified "2023-10-11" @default.
- W2040134804 title "Protective Effect of Ebselen, a Selenoorganic Drug, against Gentamicin-Induced Renal Damage in Rats" @default.
- W2040134804 cites W1482763465 @default.
- W2040134804 cites W1529962847 @default.
- W2040134804 cites W1560877971 @default.
- W2040134804 cites W1775749144 @default.
- W2040134804 cites W1971774538 @default.
- W2040134804 cites W1983310681 @default.
- W2040134804 cites W1984201510 @default.
- W2040134804 cites W1986584051 @default.
- W2040134804 cites W1986669241 @default.
- W2040134804 cites W1990078435 @default.
- W2040134804 cites W1990484506 @default.
- W2040134804 cites W1996235321 @default.
- W2040134804 cites W2006370393 @default.
- W2040134804 cites W2007653342 @default.
- W2040134804 cites W2011031755 @default.
- W2040134804 cites W2017163926 @default.
- W2040134804 cites W2034702811 @default.
- W2040134804 cites W2050100635 @default.
- W2040134804 cites W2058674735 @default.
- W2040134804 cites W2060938234 @default.
- W2040134804 cites W2071119584 @default.
- W2040134804 cites W2072949164 @default.
- W2040134804 cites W2078854975 @default.
- W2040134804 cites W2103061782 @default.
- W2040134804 cites W2124837117 @default.
- W2040134804 cites W2162539461 @default.
- W2040134804 cites W2419106528 @default.
- W2040134804 cites W3164850907 @default.
- W2040134804 cites W4295992498 @default.
- W2040134804 doi "https://doi.org/10.1111/j.1742-7843.2006.pto_474.x" @default.
- W2040134804 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16930301" @default.
- W2040134804 hasPublicationYear "2006" @default.
- W2040134804 type Work @default.
- W2040134804 sameAs 2040134804 @default.
- W2040134804 citedByCount "36" @default.
- W2040134804 countsByYear W20401348042012 @default.
- W2040134804 countsByYear W20401348042013 @default.
- W2040134804 countsByYear W20401348042014 @default.
- W2040134804 countsByYear W20401348042016 @default.
- W2040134804 countsByYear W20401348042017 @default.
- W2040134804 countsByYear W20401348042018 @default.
- W2040134804 countsByYear W20401348042019 @default.
- W2040134804 countsByYear W20401348042020 @default.
- W2040134804 countsByYear W20401348042021 @default.
- W2040134804 countsByYear W20401348042023 @default.
- W2040134804 crossrefType "journal-article" @default.
- W2040134804 hasAuthorship W2040134804A5016702063 @default.
- W2040134804 hasAuthorship W2040134804A5030821072 @default.
- W2040134804 hasAuthorship W2040134804A5068972966 @default.
- W2040134804 hasConcept C126189478 @default.
- W2040134804 hasConcept C126322002 @default.
- W2040134804 hasConcept C134018914 @default.
- W2040134804 hasConcept C181199279 @default.
- W2040134804 hasConcept C185592680 @default.
- W2040134804 hasConcept C2775832221 @default.
- W2040134804 hasConcept C2775838275 @default.
- W2040134804 hasConcept C2776151105 @default.
- W2040134804 hasConcept C2778401633 @default.
- W2040134804 hasConcept C2778760513 @default.
- W2040134804 hasConcept C2779138974 @default.
- W2040134804 hasConcept C2780091579 @default.
- W2040134804 hasConcept C2780306776 @default.
- W2040134804 hasConcept C501593827 @default.
- W2040134804 hasConcept C538909803 @default.
- W2040134804 hasConcept C55493867 @default.
- W2040134804 hasConcept C71924100 @default.
- W2040134804 hasConcept C98274493 @default.
- W2040134804 hasConceptScore W2040134804C126189478 @default.
- W2040134804 hasConceptScore W2040134804C126322002 @default.
- W2040134804 hasConceptScore W2040134804C134018914 @default.
- W2040134804 hasConceptScore W2040134804C181199279 @default.
- W2040134804 hasConceptScore W2040134804C185592680 @default.
- W2040134804 hasConceptScore W2040134804C2775832221 @default.
- W2040134804 hasConceptScore W2040134804C2775838275 @default.
- W2040134804 hasConceptScore W2040134804C2776151105 @default.
- W2040134804 hasConceptScore W2040134804C2778401633 @default.
- W2040134804 hasConceptScore W2040134804C2778760513 @default.
- W2040134804 hasConceptScore W2040134804C2779138974 @default.
- W2040134804 hasConceptScore W2040134804C2780091579 @default.
- W2040134804 hasConceptScore W2040134804C2780306776 @default.
- W2040134804 hasConceptScore W2040134804C501593827 @default.
- W2040134804 hasConceptScore W2040134804C538909803 @default.
- W2040134804 hasConceptScore W2040134804C55493867 @default.
- W2040134804 hasConceptScore W2040134804C71924100 @default.
- W2040134804 hasConceptScore W2040134804C98274493 @default.
- W2040134804 hasIssue "3" @default.
- W2040134804 hasLocation W20401348041 @default.
- W2040134804 hasLocation W20401348042 @default.
- W2040134804 hasOpenAccess W2040134804 @default.
- W2040134804 hasPrimaryLocation W20401348041 @default.